You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Overlay

Incruse Ellipta possible side effects

These pages are specifically for patients who have been prescribed Incruse Ellipta. If you are not a patient please return to the public website.

Like all medicines, Incruse Ellipta can cause side effects, although not everybody gets them.

Common Side Effects (up to 1 in 10 people) 1
  • Common cold
  • Infection of nose and throat
  • Headache
  • Cough
  • Constipation
  • Faster heart beat
  • Painful and frequent urination (may be signs of urinary tract infection)
  • Feeling of pressure or pain in the cheeks and forehead (may be signs of inflammation of the sinuses called sinusitis)
Uncommon Side Effects (up to 1 in 100 people) 1
  • Irregular heart beat
  • Rash
  • Dry mouth
  • Taste disturbance
  • Sore throat
  • Itching

Reporting side effects

If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Website: www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine.

References:

  1. Incruse Ellipta 55mcg patient information leaflet

INCRUSE Ellipta was developed in collaboration with INNOVIVA Inc.

INNOVIVA logo

▼These medicinal products are subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting side effects you may get.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to HPRA Pharmacovigilance on their website: www.hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

Incruse Ellipta are registered trademarks of the GlaxoSmithKline Group of Companies